John Muir Physician Network Clinical Research Center
Concord, California 94520
1 studies enrolling now · 28 studies all time
What they study most
Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Diseases, Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type II, Diabetic Gastroparesis, Essential Hypertension, Hypertension, Obese
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight — Completed
- A Study of CT-868 in Type 1 Diabetes Mellitus — Completed
- PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days — Completed
- A Study of Mealtime Insulin LY900014 in Participants With Type 2 Diabetes Using Continuous Glucose Monitoring (PRONTO-Time in Range) — Completed
- An Efficacy & Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets — Completed
- Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension — Completed
- A Study of LY3209590 in Participants With Type 1 Diabetes — Completed
- Glooko mHealth Advantage Study — Completed
- A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes — Completed
- A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus — Completed
- A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy — Completed
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis — Completed
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis — Completed
- An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus — Completed
- A Study of LY900014 in Participants With Type 1 Diabetes — Completed
- The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
- Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed
- Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) — Completed
- The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
- Evaluation of the Accuracy of an Implanted Glucose Sensor — Completed
- Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes — Completed
- Evaluation of the A1CNow+ Test Kit — Completed
- A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®) — Completed
- Efficacy and Safety Study of Saxagliptin + Metformin Immediate Release (IR) Versus Metformin IR Alone in Type 2 Diabetes Mellitus — Completed
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus — Completed
- Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring System — Completed